| (Values in U.S. Thousands) | Jun, 2018 | Jun, 2017 | Jun, 2016 | Jun, 2015 | Jun, 2014 |
| Sales | 2,580 | 2,380 | 3,570 | 5,440 | 330 |
| Sales Growth | +8.40% | -33.33% | -34.38% | +1,548.48% | +120.00% |
| Net Income | -6,410 | -5,690 | -5,630 | -4,930 | -12,240 |
| Net Income Growth | -12.65% | -1.07% | -14.20% | +59.72% | -53.19% |
Prana Bio Ltd Ads S1 (PRAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.